Verona Pharma plc (VRNA) Tops Q2 EPS by 2c

Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c